AG2R LA Mondiale Gestion D Actifs Takes $4.60 Million Position in Danaher Corporation $DHR

AG2R LA Mondiale Gestion D Actifs acquired a new stake in Danaher Corporation (NYSE:DHR) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 24,211 shares of the conglomerate’s stock, valued at approximately $4,598,000.

A number of other institutional investors also recently made changes to their positions in the business. Voya Investment Management LLC raised its holdings in Danaher by 1.1% during the 1st quarter. Voya Investment Management LLC now owns 886,002 shares of the conglomerate’s stock valued at $181,630,000 after buying an additional 9,926 shares during the last quarter. Howe & Rusling Inc. raised its holdings in Danaher by 103.7% during the 1st quarter. Howe & Rusling Inc. now owns 31,226 shares of the conglomerate’s stock valued at $6,401,000 after buying an additional 15,897 shares during the last quarter. Guinness Asset Management LTD raised its holdings in Danaher by 5.3% during the 1st quarter. Guinness Asset Management LTD now owns 171,960 shares of the conglomerate’s stock valued at $35,253,000 after buying an additional 8,624 shares during the last quarter. eCIO Inc. bought a new position in Danaher in the 1st quarter worth $131,000. Finally, Osterweis Capital Management Inc. raised its holdings in Danaher by 26.0% in the 1st quarter. Osterweis Capital Management Inc. now owns 128,535 shares of the conglomerate’s stock worth $26,350,000 after purchasing an additional 26,494 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $195.23 on Friday. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The company’s 50-day moving average is $201.47 and its 200 day moving average is $199.04. The company has a market capitalization of $139.79 billion, a price-to-earnings ratio of 41.54, a price-to-earnings-growth ratio of 2.69 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the prior year, the firm posted $1.72 EPS. Danaher’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Analyst Ratings Changes

Several research analysts have commented on DHR shares. UBS Group decreased their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Barclays restated an “overweight” rating and issued a $225.00 price objective (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Robert W. Baird upped their price objective on shares of Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a report on Friday, July 18th. Evercore ISI decreased their price objective on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $246.35.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.